Illuminated surgical retractor

Information

  • Patent Grant
  • 11439379
  • Patent Number
    11,439,379
  • Date Filed
    Monday, July 15, 2019
    5 years ago
  • Date Issued
    Tuesday, September 13, 2022
    2 years ago
  • Inventors
  • Original Assignees
    • OBP SURGICAL CORPORATION (Lawrence, MA, US)
  • Examiners
    • Matthews; Tessa M
    Agents
    • Cowan, Liebowitz & Latman, P.C.
    • Zhadina; Anastasia
Abstract
A surgical retractor, comprising a blade having a top surface and a bottom surface, and a handle extending at an angle from a proximal end of the blade, wherein the blade and the handle are molded from a glass-fiber reinforced polymer having a flexural strength of at least 300 Mpa, and wherein the blade, being molded from the glass-fiber reinforced polymer, deforms less than 10 mm under 15 lbs of force applied thereto.
Description
INTRODUCTION

Existing technology for illumination during surgical/medical procedures includes overhead illumination. This illumination comes from either overhead lighting or head mounted fiber optic systems. Traditional overhead lighting systems face numerous limitations. A direct exposure of the field from the overhead source is required. Changes in patient or surgeon positioning may interfere with the light source. Frequent adjustments provide an inconvenience for the surgeon and disrupt the surgical flow. Overhead lighting is frequently inadequate for surgery in deeper cavities where more intense focused illumination may be required.


In addition, the alignment of the surgeon's head frequently interferes with the remote illumination and prevents light from reaching the field. Head mounted fiber optic systems are used frequently for more limited surgical exposures. However, these devices have numerous limitations.


First, the surgeon is tethered by the light cord attached to the headset, limiting the mobility in the operating room.


Second, the devices are associated with head and neck fatigue with frequent or prolonged use.


Third, the devices require the surgeon to maintain a steady head and neck position to provide a constant and steady illumination of the field.


Fourth, the use of remote light sources and fiber bundles introduces tremendous inefficiencies into the system. A typical ten-foot long cable will lose illumination by approximately 10% per foot of cable for a 300-watt light source, which results in much lower illumination than desired.


Fifth, a head lamp's illumination is not collinear with the doctor's eyes, and may cast shadows in the field of view when illuminating surgical cavities.


Sixth, halogen bulbs get very hot and often burn the skin surrounding the surgical pocket the surgeon is working in.


Other existing technology for illumination during surgical/medical procedures includes lighted surgical retractors. These retractors include integral or attached light sources which project light locally down the retractor blade. Existing lighted surgical retractors overcome the problems with overhead illumination, but still suffer from several shortcomings. These retractors can generally be classified into two categories.


The first category includes those with detachable light sources. This category allows the retractor to be re-used and therefore the retractor must be sterilized prior to re-use. Characteristics of most light sources are not compatible with many sterilization procedures. For example, it is uncommon for batteries to carry out high temperature sterilization. It is also difficult to completely remove organic material from light source assemblies.


To overcome these difficulties, lighted surgical retractors with detachable light sources were created. These light sources are releasably attached to the retractor via tape or other adhesive or clip-on mechanism. This class of lighted surgical retractors requires assembly prior to use and disassembly, cleaning, and sterilization after use. Such assembly, disassembly, cleaning, and sterilization represent significant time, cost, and inefficiency for the user.


The second category of lighted surgical retractors consists of surgical retractors with light sources that are integrated into the retractor and are not removable. These lighted surgical retractors contain a power source in the retractor handle, an illumination device built into, or permanently attached to the blade, and some form of optical or electrical coupling between the power source and the illumination device. The power source can be batteries or a device that will plug into the wall. It could also be an optical power source that generates optical energy instead of electrical energy. The illumination device is either one or more light emitting diodes, filament light bulbs, a fiber optic cable, or an optical waveguide. The form of coupling is either wiring for an electrical connection, or a fiber optic cable or optical waveguide for optical coupling.


This second category of lighted surgical retractors eliminates the problem of assembly and disassembly from which the first category of surgical retractors suffers. But this second class of retractors still suffers from difficulty in cleaning and sterilization.


Moreover, in order to be sterilizable (i.e., to withstand the thermal trauma of high pressure steam sterilization), surgical retractors have been generally made of stainless steel. If they had any attached lighting system this required hand disassembly after use, hand cleaning and then repackaging for gas sterilization of the lighting apparatus. This device then required reassembly on the surgical table prior to use.


Also, the known techniques involved in integrating light source components into the handle and blade are generally costly. Recent evidence is emerging that procedures for cleaning and sterilization are often flawed in practice, resulting in possible cross contamination of patients. These deficiencies have prevented a widespread adoption of this second category of lighted surgical retractors.


Embodiments described herein represent a new class of lighted surgical retractors that does not suffer from these known deficiencies. These embodiments completely eliminate the risk of cross contamination by ensuring that each retractor can be only used once. These embodiments eliminate the costly electrical or optical interconnect systems required by previous retractors. These embodiments also eliminate the requirement of assembly, disassembly, cleaning, and re-sterilization by the end user.


Embodiments described herein provide an illuminated surgical retractor, which can be discarded after a single use due to its intrinsic low cost.


In one or more exemplary embodiments, an illuminated surgical retractor includes a blade, a handle, a curved section, and an illumination assembly. The blade has a top surface and a bottom surface. The handle extends at an angle from a proximal end of the blade. The curved section connects the handle to the blade. The illumination assembly includes at least one light source, at least one battery and an activation device for energizing the light source. The illumination assembly is permanently attachable to the curved section.


In one or more embodiments, a chemical capacity of the battery is sufficient for a single use.


In one or more embodiments, the illumination assembly includes a light case integrally molded.


In one or more embodiments, the illumination assembly includes a plurality of retaining tabs protruded from the light case. The illuminated surgical retractor further includes a plurality of acceptance slots and an acceptance cavity. The acceptance slots are located vertically, horizontally or at an angle with the curved section, and are configured for accepting the retaining tabs. The acceptance cavity is in communication with the acceptance slots. When the retaining tabs are inserted fully into the acceptance slots, the retaining tabs arrive at the acceptance cavity.


When compared with the prior art, the exemplary embodiments described herein have at least the following advantages:


(1) The non-directional shape of the retaining tab allows the illumination assembly to be utilized with either vertically released molds or horizontally released molds. This use of a common illumination assembly for a wide variety of retractor shapes dramatically lowers the cost of the illuminated surgical retractor.


(2) The chemical capacity of the batteries is sufficient for only a single use and the illuminated surgical retractor is discarded after the single use. The intrinsic low cost of these embodiments makes the illuminated surgical retractor economically attractive, and eliminates the inefficiency and expense of cleaning and re-sterilization.


(3) The materials and structure enable the device to be radiolucent, allowing patient imaging devices to directly view the body cavity with the retractor inserted.


(4) The materials and structure enable the device to be electroresistive, allowing the physician to utilize electrocauterizing tools in the cavity while the retractor is inserted without worry of shorting out the electrocauterizing tool.


One exemplary aspect comprises an illuminated surgical retractor, comprising: a blade having a top surface and a bottom surface; a handle extending at an angle from a proximal end of the blade; a curved section connecting the handle to the blade; and an illumination assembly comprising at least one light source, at least one battery and an activation device for energizing the light source, and the illumination assembly being permanently attached to the retractor; wherein the blade, handle, and curved section are molded from a glass-fiber reinforced polymer.


One exemplary aspect comprises an illuminated surgical retractor, comprising: a blade having a top surface and a bottom surface; a handle extending at an angle from a proximal end of the blade; a curved section connecting the handle to the blade; and an illumination assembly comprising at least one light source, at least one battery and an activation device for energizing the light source, and the illumination assembly being permanently attached to the retractor; wherein the blade, handle, and curved section are molded from a low conductivity polymer.


One exemplary aspect comprises an illuminated surgical retractor, comprising: a blade having a top surface and a bottom surface; a handle extending at an angle from a proximal end of the blade; a curved section connecting the handle to the blade; and an illumination assembly comprising at least one light source, at least one battery and an activation device for energizing the light source, and the illumination assembly being permanently attached to the curved section; wherein the blade, handle, and curved section are molded from a radiolucent polymer.


In various embodiments: (1) the polymer is a 50% glass-fiber reinforced polymer; (2) the polymer is a polyarylamide compound; (3) the polymer is a thermoplastic crystalline polymer; (4) the polymer is a thermoplastic crystalline polymer of aromatic diamines and aromatic dicarboxylic anhydrides; (5) the polymer is a glass-fiber reinforced polyacrylamide; (6) the polymer is at least 50% glass-fiber reinforced; (7) the polymer has a flexural modulus of at least 17 Gpa; (8) the polymer has a flexural strength of at least 375 Mpa; (9) the polymer has an impact strength of at least 100 J/M; (10) the illumination assembly is permanently attached to the curved portion; and/or (11) the polymer has a conductivity of less than 10-6 A.


Further features and advantages will be apparent to those skilled in the art after reviewing the drawings and detailed description provided herein.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic view of an illuminated surgical retractor according to an embodiment of the present disclosure.



FIG. 2 is a rear view of the illuminated surgical retractor of FIG. 1.



FIG. 3 is a side view of the illuminated surgical retractor of FIG. 1.



FIG. 4 is an exploded view of the illuminated surgical retractor of FIG. 1.



FIG. 5 is a schematic view of the illumination assembly of the illuminated surgical retractor of FIG. 1.



FIG. 6 is a front view of the illumination assembly of FIG. 5.



FIG. 7 is a partially enlarged view of the illuminated surgical retractor of FIG. 1 with the illumination assembly removed.



FIG. 8 is a partially enlarged view of the illuminated surgical retractor of FIG. 1 with the illumination assembly removed.



FIG. 9 is a fluoroscopy image illustrating the radiolucency of an embodiment.



FIG. 10 illustrates flexural strength and flexural modulus for a variety of plastics.





DETAILED DESCRIPTION OF SELECT EMBODIMENTS

Drawings will be used herein to describe select exemplary embodiments. For the sake of clear illustration, many practical details will be explained together in the description below. However, it should be appreciated that the practical details should not be used to limit the claim scope. In other words, in some embodiments, certain details are not essential. Moreover, for the sake of drawing simplification, some customary structures and elements in the drawings will be schematically shown in a simplified way. Wherever possible, the same reference numbers are used in the drawings and the description to refer to the same or like parts.


Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art. It should be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and the present description, and should not be interpreted in an idealized or overly formal sense unless expressly so defined herein.



FIG. 1 is a schematic view of an illuminated surgical retractor 10 according to an exemplary embodiment. FIG. 2 is a rear view of the illuminated surgical retractor 10 of FIG. 1. As shown in FIGS. 1-2, an illuminated surgical retractor 10 includes a blade 11, a handle 12, a curved section 16 and an illumination assembly 50. The blade 11 has a top surface 14 and a bottom surface. The handle 12 extends at an angle from a proximal end of the blade 11. The curved section 16 connects the handle 12 to the blade 11. The illumination assembly 50 includes at least one light source 64, at least one battery 62 and an activation device for energizing the light source 64. The illumination assembly 50 is attachable to the curved section 16.


Furthermore, the blade 11 and the handle 12 are joined together at an angle through the curved section 16 to form a retractor component 15. In practical applications, the blade 11, the handle 12, and the curved section 16 are integrally molded as a single piece. In addition, in this embodiment, the angle may be in a range of, for instance, 35 to 170 degrees, and can particularly be 90 degrees. The retractor component 15 may be made of any material, but preferably high strength plastic such as ABS or polyarylamide and made by a low cost manufacturing process such as injection molding. The top surface 14 of the blade 11 may be concave (or flat, or convex).


The blade 11 may have uniform width or may be shaped such that the distal end Is wider or narrower than the proximal end. The blade 11 may have a lip at the end of it for retaining tissue, or may be curved as shown to prevent retention of tissue. In this embodiment, the handle 12 is in a rectangular form, but in other embodiments, the handle 12 may be circular or oval in shape, and may be opened on one or more sides. The illumination assembly 50 is integrated into the angular space connecting the blade 11 with the handle 12. Integration into this angular space allows the batteries 62 and the illumination assembly 50 to reside in a light enclosure 51 and eliminates the electrical or optical coupling requirements in previous disclosures.



FIG. 3 is a side view of the illuminated surgical retractor 10 of FIG. 1. In this embodiment, as shown in FIG. 3, the removal of pull tab 63 is used to energize the illumination assembly 50. Other embodiments may include the use of an electrical switch.



FIG. 4 is an exploded view of the illuminated surgical retractor 10 of FIG. 1. The light source 64 is used to provide illumination to the area of the blade 11 of the illuminated surgical retractor 10. The light source 64 can be any suitable light source, such as, for example, a light emitting diode (LED), an incandescent element, or a fluorescent element.


In this embodiment, the light source 64 is angled so that substantially all of the light travels to the distal end of the blade 11. In other embodiments, the light source 64 can be angled so as to provide substantially all of the light above the blade 11, or at other angles to the blade 11 that are preferable for the medical application of the illuminated surgical retractor 10.


The batteries 62 provide power to the light source 64. The batteries 62 are small enough to be contained in the angled space between the blade 11 and the handle 12. Examples of the batteries 62 include LR41 or AG3 type button batteries. These batteries 62 are of a very low price. In this embodiment, three batteries 62 are used to provide power to the light source 64. Three batteries 62 eliminate the need for expensive circuitry to condition the voltage and current required by the light source 64. These batteries 62 contain sufficient energy for 20-40 minutes of use, which is sufficient for the vast majority of medical procedures. In other embodiments, a different number and type of batteries 62 can be used with or without conditioning circuitry.



FIG. 5 is a schematic view of the illumination assembly 50 of the illuminated surgical retractor 10 of FIG. 1. FIG. 6 is a front view of the illumination assembly 50 of FIG. 5. The light case 51 contains the light source 64, the batteries 62, a spring 51, and the pull tab 63. The light source 64 has electrical leads 65 and 66 which are cut to an appropriate length and bent such that the electrical lead 65 makes an electrical contact with the anode or cathode of one battery 62 and the electrical lead 66 makes an electrical contact with the spring 61. In this embodiment, the spring 61 is made of a metal such as stainless steel. In other embodiments, other electrically conductive materials suitable for producing a spring may be used. The spring 61 makes an electrical contact with the opposite battery polarity other than that previously mentioned, and the spring 61 makes this contact with one battery 62.


The spring 61 is assembled in a compressed condition such that the spring 62 applies a force to the batteries 62, the pull tab 63, and the light source leads 65 and 66. This force ensures electrical contact between the batteries 62, the light source leads 65 and 66, the spring 61, and the pull tab 63. The pull tab 63 is made of an electrically insulative material such as polymer, plastic, or film. The pull tab 63 prevents an electric current from flowing to the light source 64 while the pull tab 63 is inserted between two of the batteries 62. The removal of the pull tab 63 will cause the spring 61 to push together the batteries 62 and allow an electric current to flow to the light source 64. Thus, light is emitted from the light source 64. The application of the pull tab 63 is a very low cost method to control the energizing of the electrical circuit. In other embodiments, a switch may be utilized instead of the pull tab 63 to complete the circuit of the batteries 62 and the light source 64. One having ordinary skill in the art will understand these other embodiments.


As shown in FIGS. 5-6, the illumination assembly 50 includes a light case 51. Retaining tabs 52 protrude from the light case 51. The light case 51 is integrally molded and in this embodiment is made of a moldable material such as plastic or nylon, although in other embodiments other materials may be used. Moreover, the illumination assembly 50 includes a plurality of retaining tabs 52. To be more specific, the retaining tabs 52 are located at the distal end of the legs 53, and are protruded at right angles to the legs 53. In this embodiment, the retaining tabs 52 are initially compressed when inserted into acceptance slots 71 (not shown in FIGS. 5-6).



FIGS. 7-8 are partially enlarged views of the illuminated surgical retractor 10 of FIG. 1 with the illumination assembly 50 removed. As shown in FIGS. 7-8, the illuminated surgical retractor 10 further includes a plurality of acceptance slots 71 and an acceptance cavity 72. The acceptance slots 71 are located vertically, horizontally, or at an angle with the curved section 16, and are configured for accepting the retaining tabs 52. The acceptance slots 71 are in communication with the acceptance cavity 72 (shown in FIG. 8). When the retaining tabs 52 are inserted fully into the acceptance slots 71, the retaining tabs 52 arrive at the acceptance cavity 72. The acceptance cavity 72 is arranged to remove compression on the retaining tabs 52 and will inhibit the removal of the retaining tab 52 from the acceptance cavity 72. In this embodiment, the acceptance cavity 72 is recessed into the retractor component 15 such that the retaining tabs 52 will not protrude from the surface of retractor component 15. The lack of any protrusion allows for a smooth surface of the blade 11 and the handle 12, and an angled area between the blade 11 and the handle 12 prevents tissue irritation during medical procedures.


The retaining tabs 52, the retaining legs 53, the acceptance slots 71, and the acceptance cavity 72 allow novel flexibility in the creation of injection molds for the retractor component 15. In this embodiment, the injections slots are vertical, as required for molds that are designed to be released vertically. One having ordinary skill in the art of injection molding will recognize that the shape of the retractor component 15 requires molds that release vertically.


Other embodiments of the retractor component 15 may contain shapes that require horizontal mold releases and thus will have horizontal acceptance slots and cavities. The non-directional shape of the retaining tab 52 allows the illumination assembly 50 to be utilized with either vertically released molds or horizontally released molds. The use of a common illumination assembly 50 for a wide variety of retractor shapes dramatically lowers the cost of the illuminated surgical retractor 10.


The embodiments described herein provide a novel, low cost illumination assembly 50 attached in a unique location of the illuminated surgical retractor 10 which eliminates the expensive electrical and/or optical interconnection between the handle 12 and the blade 11 of previous retractors.


The illumination assembly 50 is attached to the illuminated surgical retractor 10 in a novel way so as to be compatible with a wide assortment of retractor shapes which can be molded vertically or horizontally. The chemical capacity of the batteries 62 is sufficient for only a single use and the illuminated surgical retractor is discarded after the single use. The intrinsic low cost of these embodiments makes the illuminated surgical retractor 10 economically attractive, and eliminates the inefficiency and expense of cleaning and re-sterilization. Recent evidence is emerging that procedures for cleaning and sterilization are often flawed in practice, resulting in possible cross contamination of patients. The embodiments described herein completely eliminate the risk of cross contamination by ensuring that each of the illuminated surgical retractor 10 is only used once.


In one or more embodiments, the blade, the handle and the curved section (referred to herein collectively as “the body”) are integrally molded. In at least one exemplary embodiment, the material of which the body is formed is a strong, rigid, lightweight plastic (e.g., a polymer). One example of a suitable plastic is a glass-fiber reinforced polyarylamide compound that provides high strength and rigidity, surface gloss, and creep resistance. An exemplary embodiment uses a 50% glass-fiber reinforced polyarylamide compound, but those skilled in the art will understand that other percentages may be used without departing from the spirit and scope of the claimed invention.


Polyarylamides are thermoplastic crystalline polymers of aromatic diamines and aromatic dicarboxylic anhydrides having good heat, fire, and chemical resistance, property retention at high temperatures, dielectric and mechanical properties, and stiffness but low light resistance and processability. Those skilled in the art will understand that other plastics with suitable strength and rigidity also may be used.


In one or more embodiments, the body is made of a plastic (such as glass-fiber reinforced polyarylamide) having properties of at least one of radiolucence and nonconductivity. As used herein, “radiolucence” means high transparency to radiation, so that the device may be used when taking, for example, x-ray images. “Nonconductive,” as used herein, means essentially dielectric.


An advantage of radiolucence is that the device may be used when taking X-ray images, without obscuring essential structures, as shown in FIG. 9. The “OBP” in FIG. 9 resulted from metal lettering placed below the blades of an embodiment to show the radiolucency. The much darker image on the left is of a stainless steel comparison blade, which shows up as black due to its opacity with respect to X-rays.


Embodiments described herein may provide light to the tip of the retractor and still remain highly (as much as 99%) radiolucent. Prior art devices have, for example, fiber optic cables that obstruct the view when X-ray images are taken, even when the devices are constructed of plastic. Metal devices are, of course, not radiolucent at all.


This radiolucent property means that retractors described herein may not need to be removed prior to the use of imaging techniques in surgical procedures. This can expedite the conduct of a procedure needing anatomic identification and/or device localization.


An advantage of nonconductivity is that it provides improved safety to patients—in contrast to metal retractors. Currents as low as 0.001 A may be felt by a patient, and larger currents may damage the patient. Embodiments described herein limit currents to less than 10−6 A, and thus greatly reduce electrical hazards.


For example, electro-cautery is used extensively in surgical tissue dissection. The use of metal retractors exposes the operating surgeon and the patient to the risk of retracted tissue damage due to destructive cautery current being conducted inadvertently. Retractors are often used to displace and retract delicate cautery sensitive tissues such small or large bowel (colon), lung, or major blood vessels. Cautery injury to these tissues can create major complications. In addition, retractors are often used to develop surgical tissue pockets in breast and pacemaker surgery. Use of a non-electrical conducting material, such as is described herein with respect to certain embodiments, prevents any stray electrical energy injury to the retracted tissues. Patient safety is thus enhanced.


As those skilled in the art will understand, strength is a function of both the material and the design. Designs using weaker material than is described herein need to be thicker and more rounded. Both of these traits will decrease the favorability of a retractor, which should not block visibility of the body cavity.


Flexural Strength represents the limit before a material will break under stress. Flexural modulus is the tendency of the material to bend under stress. Both of these parameters are critical to retractor design and resulting performance. First, a retractor blade must be thin enough to not interfere with the medical procedure for which it is used. Very thick blades will tend to fill the hole in the body that the physician needs to work in. An optimal design will have a blade thin enough to allow space for the physician to work. Typically metal blades are used because of their high Flexural modulus. They have unlimited flexural strength, because they bend rather than break. Metal blades as thin as 0.5-2 mm are readily available and this thickness is small enough to not interfere with the physician's work space in a wound or operating cavity. Stainless steel metal can have a flexural modulus of 180 Gpa which will inhibit blade deformation of more than 10 mm under 15 lbs of tip pressure for most retractor designs.


Plastic injection molded blades require a thicker blade because they have a lower Flexural Modulus. Blade strength will increase as the cube of the blade thickness, but blade thicknesses larger than 2 mm are not desirable in most physician applications. Typical plastic materials, such as those shown in Table 1 below, have a Flexural Modulus of just a few Gpa and a Flexural Strength of less than 200 Mpa. These lower value parameters result in retractor blades that deform more than 10 mm under use, and are likely to break with less than 30 lbs of force placed on the tip of an average length retractor blade (50-150 mm long).


Retractor blades that deform significantly during use increase the physician's difficulty in retracting the tissue during a medical procedure. Retractor blades that break with less than 30 lbs of force can create a hazard to the patient since a broken blade, or pieces of a broken blade, may fall into the patient and create damage. Retractor blades made from the plastics listed in the following table will typically bend more than 20 mm under 10 lbs of tip force, and will break at 15 lbs (or even less) of tip force.









TABLE 1







TYPICAL FLEXURAL STRENGTH AND


FLEXURAL MODULUS OF POLYMERS










FLEXURAL
FLEXURAL



STRENGTH
STRENGTH


POLYMER TYPE
(MPa)
(MPa)












Polyamide-lmide
175
5


Polycarbonate
90
2.3


Polyethylene, MDPE
40
0.7


Polyethylene
80
1


Terephthalte (PET)









To increase the Flexural modulus and Flexural strength of plastic, in an embodiment, glass fiber is added to the plastic material. FIG. 10 shows a variety of plastics with various percentages of glass fiber added.


It can be seen from the above that the addition of glass fiber can increase the Flexural Strength of certain plastics to 300 Mpa or above, and increase the Flexural Modulus to 16 Gpa or above. In an exemplary embodiment, a certain type of plastic, polyacrylamide is infused with glass fiber to create a flexural strength of over 375 Gpa and a Flexural modulus of over 17 Gpa.


Plastics with these properties have the ability to create retractor blades of approximately 2 mm thickness that withstand over 30 lbs of tip force without breaking and deform less than 10 mm under 15 lbs of force. Additionally, the glass fiber in this material will “glassify” at the surface leaving a very smooth “metal like” finish which is highly desirable in retractor applications.


The glass fiber in the material also will decrease the likelihood of sharp shards of material being created during an overstress and breakage event. This tendency to create dull edges upon breakage decreases the likelihood that a patient will experience damage if the retractor is overstressed and ultimately broken.


Additionally, the way in which a material breaks can be important in medical applications. The breakage characteristics of a material are often measured by Impact Strength. Materials with low impact strength (10-20 J/M) can break under stress into large numbers of sharp shards which can pose a hazard to a patient if material failure occurs during a medical procedure. Sharp shards can cut patient tissue and large numbers of these shards can make it difficult or impossible to remove the broken material from the patient.


Materials (such as glass fiber reinforced polyarylamide) used in certain embodiments described herein have a high impact strength (>100 J/M) and will fail with very few fractured component edges (and the resulting edges will be blunt). This breakage characteristic minimizes potential hazard to a patient during product overstress that results in material breakage.


In summary, when compared with the prior art, one or more embodiments described herein have at least the following advantages:


(1) The non-directional shape of the retaining tab allows the illumination assembly to be utilized with either vertically released molds or horizontally released molds. This use of a common illumination assembly for a wide variety of retractor shapes dramatically lowers the cost of the illuminated surgical retractor.


(2) The chemical capacity of the batteries is sufficient for only a single use and the illuminated surgical retractor is discarded after the single use. The intrinsic low cost of these embodiments makes the illuminated surgical retractor economically attractive, and eliminates the inefficiency and expense of cleaning and re-sterilization. Moreover, using an LED light source as opposed to halogen is advantageous since halogen bulbs get very hot and often burn the skin surrounding the surgical pocket in which a surgeon is working.


(3) The materials used to construct the retractor provide significant safety and advantages over prior art retractors, including, but not limited to, at least one of the following: (a) no danger from insufficient re-sterilization; (b) nonconductivity; (c) radiolucence; (d) high flexural strength and modulus; and (e) high impact strength.


Although the invention has been described in considerable detail herein with reference to certain embodiments thereof, other embodiments are possible. Therefore, the spirit and scope of the appended claims should not be limited to any non-claimed details of the embodiments contained herein.


It will be apparent to the person having ordinary skill in the art that various modifications and variations can be made to the structure of the embodiments described herein without departing from the scope or spirit of the claimed invention. In view of the foregoing, it is intended that the claimed inventions cover modifications and variations of the embodiments described herein provided they fall within the scope of the following claims.

Claims
  • 1. A surgical retractor, comprising: a blade having a top surface and a bottom surface; anda handle;a deepened concave portion connecting a proximal end of the blade to the handle,wherein the deepened concave portion increases in depth from the proximal end of the blade toward the handle,wherein the blade and the handle are molded from a glass-fiber reinforced polymer having a flexural strength of at least 300 Mpa; andwherein the blade, being molded from the glass-fiber reinforced polymer, deforms less than 10 mm under 15 lbs of force applied thereto.
  • 2. The surgical retractor of claim 1, wherein the polymer is a 50 wt % glass-fiber reinforced polymer.
  • 3. The surgical retractor of claim 1, wherein the polymer is a thermoplastic crystalline polymer.
  • 4. The surgical retractor of claim 3, wherein the polymer is a thermoplastic crystalline polymer of aromatic diamines and aromatic dicarboxylic anhydrides.
  • 5. The surgical retractor of claim 1, wherein the polymer has a flexural modulus of at least 17 Gpa.
  • 6. The surgical retractor of claim 1, wherein the polymer has a flexural strength of at least 375 Mpa.
  • 7. The surgical retractor of claim 1, wherein the polymer has an impact strength of at least 100 J/M.
  • 8. The surgical retractor of claim 1, wherein a proximal tip of the blade withstands over 30 lbs of force applied thereto.
  • 9. The surgical retractor of claim 1, wherein the polymer has a flexural modulus of at least 16 Gpa.
  • 10. The surgical retractor of claim 1, wherein the blade has a thickness of 2 mm.
  • 11. A surgical retractor, comprising: a blade having a top surface and a bottom surface; anda handle;a deepened concave portion connecting a proximal end of the blade to the handle,wherein the deepened concave portion increases in depth from the proximal end of the blade toward the handle,wherein the blade and the handle are molded from a polymer, said polymer being a low conductivity polymer and a radiolucent polymer;wherein said polymer has a flexural strength of at least 300 Mpa; andwherein the blade, being molded from the polymer, deforms less than 10 mm under 15 lbs of force applied thereto.
  • 12. The surgical retractor of claim 11, wherein the polymer has a flexural modulus of at least 16 Gpa.
  • 13. The surgical retractor of claim 11, wherein the polymer is a 50 wt % glass-fiber reinforced polymer.
  • 14. The surgical retractor of claim 11, wherein the polymer is a polyarylamide compound.
  • 15. The surgical retractor of claim 11, wherein the polymer is a thermoplastic crystalline polymer.
  • 16. The surgical retractor of claim 15, wherein the polymer is a thermoplastic crystalline polymer of aromatic diamines and aromatic dicarboxylic anhydrides.
  • 17. The surgical retractor of claim 11, wherein the polymer comprises a non-conductive material that limits currents to less than 10′ A.
  • 18. The surgical retractor of claim 11, wherein the blade has a thickness of 2 mm.
  • 19. A surgical retractor, comprising: a blade having a top surface and a bottom surface; anda handle;a deepened concave portion connecting a proximal end of the blade to the handle,wherein the deepened concave portion increases in depth from the proximal end of the blade toward the handle,wherein the blade and the handle are molded from a low conductivity polymer,wherein the polymer comprises a non-conductive material that limits currents to less than 10−6 A, andwherein a proximal tip of the blade withstands over 30 lbs of force applied thereto.
  • 20. The surgical retractor of claim 19, wherein the blade, being molded from the polymer, deforms less than 10 mm under 15 lbs of force applied thereto.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/178,675 filed on Jun. 10, 2016, which is a continuation-in-part of U.S. patent application Ser. No. 14/614,413, filed on Feb. 5, 2015, and entitled “Illuminated Surgical Retractor.” The entire contents of both priority applications are incorporated herein by reference.

US Referenced Citations (468)
Number Name Date Kind
559122 Daily Apr 1896 A
659182 Pilling Oct 1900 A
2235979 Brown Mar 1941 A
2247458 Shepard Jun 1941 A
2482971 Golson Sep 1949 A
2592190 Rubens et al. Apr 1952 A
3324850 Gunning et al. Jun 1967 A
3332414 Gasper Jul 1967 A
3532088 Fiore Oct 1970 A
3592199 Ostensen Jul 1971 A
3595222 Vellacott Jul 1971 A
3638644 Reick Feb 1972 A
3650266 Pestka et al. Mar 1972 A
3675641 Fiore Jul 1972 A
3716047 Moore et al. Feb 1973 A
3729006 Wilder et al. Apr 1973 A
3762400 McDonald Oct 1973 A
3769968 Blount et al. Nov 1973 A
3789835 Whitman Feb 1974 A
3815585 Fiore Jun 1974 A
3826248 Gobels Jul 1974 A
3851642 McDonald Dec 1974 A
3934578 Heine Jan 1976 A
3945371 Adelman Mar 1976 A
3978850 Moore et al. Sep 1976 A
4067323 Troutner Jan 1978 A
4156424 Burgin May 1979 A
4210133 Castaneda Jul 1980 A
4226228 Shin et al. Oct 1980 A
4263899 Burgin Apr 1981 A
4300541 Burgin Nov 1981 A
4337763 Petrassevich Jul 1982 A
4432351 Hoary Feb 1984 A
4492220 Hayes Jan 1985 A
4502468 Burgin Mar 1985 A
4527553 Upsher Jul 1985 A
4546761 McCullough Oct 1985 A
4551129 Coleman et al. Nov 1985 A
4562832 Wilder Jan 1986 A
4566439 Burgin Jan 1986 A
4574784 Soloway Mar 1986 A
4597383 Van Der Bel Jul 1986 A
4607623 Bauman Aug 1986 A
4619248 Walsh Oct 1986 A
4638792 Burgin Jan 1987 A
4766887 Cecil, Jr. et al. Aug 1988 A
4807600 Hayes Feb 1989 A
4884559 Collins Dec 1989 A
4905670 Adair Mar 1990 A
4934352 Sullivan, Jr. Jun 1990 A
4971036 Collins Nov 1990 A
5018507 Montaldi May 1991 A
5026368 Adair Jun 1991 A
5054906 Lyons, Jr. Oct 1991 A
5063908 Collins Nov 1991 A
5143054 Adair Sep 1992 A
5165387 Woodson Nov 1992 A
5174278 Babkow Dec 1992 A
5179937 Lee Jan 1993 A
5179938 Lonky Jan 1993 A
5222271 Eganhouse Jun 1993 A
D337384 Schucman Jul 1993 S
5231973 Dickie Aug 1993 A
5318009 Robinson Jun 1994 A
5329938 Lonky Jul 1994 A
5427152 Weber Jun 1995 A
5438976 Nash Aug 1995 A
5465709 Dickie et al. Nov 1995 A
5499964 Beck et al. Mar 1996 A
5512038 O'Neal et al. Apr 1996 A
5553627 Newkirk Sep 1996 A
5695492 Brown Dec 1997 A
5716329 Dieter Feb 1998 A
5785648 Min Jul 1998 A
5840013 Lee et al. Nov 1998 A
5846249 Thompson Dec 1998 A
5865729 Meehan Feb 1999 A
5873820 Norell Feb 1999 A
5879304 Schuchman et al. Mar 1999 A
5888195 Schneider Mar 1999 A
5899854 Slishman May 1999 A
5916150 Sillman Jun 1999 A
5967971 Bolser Oct 1999 A
6001077 Ellman et al. Dec 1999 A
6004265 Hsu et al. Dec 1999 A
6036638 Nwawka Mar 2000 A
6036713 Kieturakis Mar 2000 A
6048308 Strong Apr 2000 A
6080105 Spears Jun 2000 A
6130520 Wawro et al. Oct 2000 A
6176824 Davis Jan 2001 B1
6186944 Tsai Feb 2001 B1
6217512 Salo et al. Apr 2001 B1
6231505 Martin May 2001 B1
6231506 Hu et al. May 2001 B1
6254247 Carson Jul 2001 B1
6277067 Blair Aug 2001 B1
6319199 Sheehan et al. Nov 2001 B1
6346085 Schiffman Feb 2002 B1
6359644 Salvati Mar 2002 B1
6361489 Tsai Mar 2002 B1
6379296 Baggett Apr 2002 B1
6379299 Borodulin et al. Apr 2002 B1
6394111 Jacobs et al. May 2002 B1
6394950 Weiss May 2002 B1
6413208 Schöllhorn et al. Jul 2002 B1
6416465 Brau Jul 2002 B2
6428180 Karram et al. Aug 2002 B1
6432045 Lemperle et al. Aug 2002 B2
6432049 Banta Aug 2002 B1
6436033 Tan Aug 2002 B2
6450952 Rioux Sep 2002 B1
6468206 Hipps et al. Oct 2002 B1
6468232 Ashton-Miller et al. Oct 2002 B1
6487440 Deckert et al. Nov 2002 B2
6504985 Parker et al. Jan 2003 B2
6523973 Galli Feb 2003 B2
6524259 Baxter-Jones et al. Feb 2003 B2
6569091 Diokno et al. May 2003 B2
6589168 Thompson Jul 2003 B2
6595917 Nieto Jul 2003 B2
6616603 Fontana Sep 2003 B1
6626825 Tsai Sep 2003 B2
6663576 Gombrich et al. Dec 2003 B2
6676598 Rudischhauser et al. Jan 2004 B2
6719688 Pecherer et al. Apr 2004 B2
6761687 Doshi Jul 2004 B1
6830547 Weiss Dec 2004 B2
6896653 Vail, III et al. May 2005 B1
7014340 Betis Mar 2006 B2
7029439 Roberts et al. Apr 2006 B2
D520464 Strong May 2006 S
7223223 Lindsay May 2007 B2
7276025 Roberts et al. Oct 2007 B2
7306559 Williams Dec 2007 B2
7474820 Vayser et al. Jan 2009 B2
7492116 Oleynikov et al. Feb 2009 B2
7510524 Vayser et al. Mar 2009 B2
7631981 Miller et al. Dec 2009 B2
7736304 Pecherer Jun 2010 B2
7758203 McMahon et al. Jul 2010 B2
7878973 Yee et al. Feb 2011 B2
7901353 Vayser et al. Mar 2011 B2
7909759 Pecherer Mar 2011 B2
7967809 Jay-Robinson Jun 2011 B2
8012089 Bayat Sep 2011 B2
3052702 Hess et al. Nov 2011 A1
8047987 Grey et al. Nov 2011 B2
8088066 Grey et al. Jan 2012 B2
8096945 Buchok et al. Jan 2012 B2
8142352 Vivenzio et al. Mar 2012 B2
8142353 Pecherer et al. Mar 2012 B2
8157728 Danna et al. Apr 2012 B2
8162824 Vayser et al. Apr 2012 B2
8162826 Pecherer et al. Apr 2012 B2
8251898 Pecherer Aug 2012 B2
8285093 Vayser et al. Oct 2012 B2
8292805 Vayser et al. Oct 2012 B2
8317693 Grey et al. Nov 2012 B2
8388523 Vivenzio et al. Mar 2013 B2
8394017 Kieffer Mar 2013 B2
8435175 McMahon et al. May 2013 B2
8512234 Grey et al. Aug 2013 B2
8512237 Bastia Aug 2013 B2
8555892 Traub Oct 2013 B2
8594472 Vayser et al. Nov 2013 B2
8596847 Vayser et al. Dec 2013 B2
8628879 Pecherer et al. Jan 2014 B2
8651704 Gordin et al. Feb 2014 B1
8708896 Vayser et al. Apr 2014 B2
8795162 Vayser et al. Aug 2014 B2
8821385 Naito Sep 2014 B2
8870761 Vayser et al. Oct 2014 B2
D719652 Swift Dec 2014 S
8899809 Vayser et al. Dec 2014 B2
8979745 Swift Mar 2015 B2
9005115 Vayser Apr 2015 B2
9044161 Vayser et al. Jun 2015 B2
9050048 Nadershahi Jun 2015 B2
9072452 Vayser et al. Jul 2015 B2
9072455 Vayser et al. Jul 2015 B2
D745669 Swift Dec 2015 S
9229165 Vayser et al. Jan 2016 B2
9241617 Grey et al. Jan 2016 B2
D752217 Swift Mar 2016 S
9271709 Grey et al. Mar 2016 B2
9271710 Grey et al. Mar 2016 B2
9282878 Grey et al. Mar 2016 B2
D753295 Vivenzio et al. Apr 2016 S
9307897 Swift Apr 2016 B2
9308054 Vayser et al. Apr 2016 B2
9332898 McMahon et al. May 2016 B2
9429746 Vayser et al. Aug 2016 B2
9468366 Grey et al. Oct 2016 B2
9504373 Vayser et al. Nov 2016 B2
9510737 Vayser et al. Dec 2016 B2
9532706 McMahon et al. Jan 2017 B2
9574742 Vayser et al. Feb 2017 B2
9629529 Indovina et al. Apr 2017 B1
9636182 Vayser et al. May 2017 B2
9718130 Vayser et al. Aug 2017 B1
9763743 Lin et al. Sep 2017 B2
9808231 Miraki et al. Nov 2017 B2
9814377 Lia et al. Nov 2017 B2
9820638 Cheng Nov 2017 B2
9820729 Miles et al. Nov 2017 B2
9826892 Dresher et al. Nov 2017 B2
9833295 Vayser et al. Dec 2017 B2
9833308 Dye Dec 2017 B2
9844364 Grey et al. Dec 2017 B2
9861349 Nadershahi et al. Jan 2018 B2
9867531 Pacey et al. Jan 2018 B2
9877639 Grey et al. Jan 2018 B2
9877644 Greenstein et al. Jan 2018 B2
D809660 Nguyen et al. Feb 2018 S
9883792 McMahon et al. Feb 2018 B2
9888957 Wolf et al. Feb 2018 B2
9907544 Nadershahi et al. Mar 2018 B2
9913682 Wolf et al. Mar 2018 B2
9918618 Molnar Mar 2018 B2
9918802 Coppersmith et al. Mar 2018 B2
9931028 Lia et al. Apr 2018 B2
9943295 King Apr 2018 B2
9949814 Alexander et al. Apr 2018 B2
9955858 Pamnani et al. May 2018 B2
9968262 Greenstein et al. May 2018 B2
9968346 Alexander et al. May 2018 B2
9980710 Seifert et al. May 2018 B2
9986901 Grey et al. Jun 2018 B2
9986903 Nadershahi et al. Jun 2018 B2
9986988 Ferro et al. Jun 2018 B2
9999345 Vayser et al. Jun 2018 B2
10004392 Millard et al. Jun 2018 B2
10004393 Kucklick Jun 2018 B2
10028648 Goldfain et al. Jul 2018 B2
10028649 Salvati et al. Jul 2018 B2
10028780 Wolf et al. Jul 2018 B2
10045686 Ou Yang et al. Aug 2018 B2
10045731 Prasad et al. Aug 2018 B2
10052432 Dexter et al. Aug 2018 B2
10064611 Ross et al. Sep 2018 B2
10064613 Davis et al. Sep 2018 B2
10068173 Vayser et al. Sep 2018 B2
10092176 Kienzle et al. Oct 2018 B2
10092281 Perler et al. Oct 2018 B2
10098530 McMahon et al. Oct 2018 B2
10105043 George Oct 2018 B2
10117646 Friedrich et al. Nov 2018 B2
10130441 Martinez Nov 2018 B2
10166016 Shimizu et al. Jan 2019 B2
10172601 Ahn Jan 2019 B2
10174933 Phillips, Jr. et al. Jan 2019 B2
10188298 Greenstein et al. Jan 2019 B2
10213271 Duggal et al. Feb 2019 B2
10219800 Tsubouchi Mar 2019 B2
10220445 Vayser et al. Mar 2019 B2
10226555 Vayser et al. Mar 2019 B2
10238462 Wood et al. Mar 2019 B2
D846119 Greeley et al. Apr 2019 S
10278571 Poormand May 2019 B2
10292782 Haverich et al. May 2019 B2
10292784 Duggal et al. May 2019 B2
10321969 Wayne et al. Jun 2019 B2
10342525 Wilson Jul 2019 B2
10456190 Vayser et al. Oct 2019 B2
10499974 Heim et al. Dec 2019 B2
10500010 Vayser et al. Dec 2019 B2
10512518 Vayser et al. Dec 2019 B2
10512520 Wayne et al. Dec 2019 B2
10531933 Vayser et al. Jan 2020 B2
10548682 Vayser et al. Feb 2020 B2
10568712 Vayser et al. Feb 2020 B2
10675115 Vayser et al. Jun 2020 B2
10729511 Vayser et al. Aug 2020 B2
10729512 Wayne et al. Aug 2020 B2
20010029044 Gombrich et al. Oct 2001 A1
20020022769 Smith et al. Feb 2002 A1
20020038075 Tsai Mar 2002 A1
20020038076 Sheehan et al. Mar 2002 A1
20020055670 Weiss May 2002 A1
20020115909 Bolser Aug 2002 A1
20020156350 Nieto Oct 2002 A1
20020165435 Weiss Nov 2002 A1
20020198471 Baxter-Jones et al. Dec 2002 A1
20030095781 Willaims May 2003 A1
20030105387 Frumovitz et al. Jun 2003 A1
20030139673 Vivenzio et al. Jul 2003 A1
20030158502 Baxter-Jones et al. Aug 2003 A1
20030176772 Yang Sep 2003 A1
20030187331 Faludi et al. Oct 2003 A1
20040026829 Van Der Weegen Feb 2004 A1
20040054260 Klaassen et al. Mar 2004 A1
20040141175 Baldwin et al. Jul 2004 A1
20040183482 Roberts et al. Sep 2004 A1
20040184288 Bettis Sep 2004 A1
20040186355 Strong Sep 2004 A1
20040254428 Ritland Dec 2004 A1
20050065496 Simon et al. Mar 2005 A1
20050085699 Weiss Apr 2005 A1
20050085723 Huebner Apr 2005 A1
20050093718 Martin May 2005 A1
20050125015 McNally-Heintzelman et al. Jun 2005 A1
20050159649 Patel Jul 2005 A1
20050182301 Acker Aug 2005 A1
20050192482 Carpenter Sep 2005 A1
20050215858 Vail, III Sep 2005 A1
20050240081 Eliachar Oct 2005 A1
20050277811 Richards et al. Dec 2005 A1
20060084843 Sommerich et al. Apr 2006 A1
20060122463 Klaassen Jun 2006 A1
20060155276 Walulik et al. Jul 2006 A1
20060189847 Yee et al. Aug 2006 A1
20060200186 March et al. Sep 2006 A1
20070043264 Gillis et al. Feb 2007 A1
20070060795 Vayser et al. Mar 2007 A1
20070060938 Dziadik et al. Mar 2007 A1
20070066872 Morrison et al. Mar 2007 A1
20070100212 Pimenta et al. May 2007 A1
20070208226 Grey et al. Sep 2007 A1
20070230164 Vivenzio et al. Oct 2007 A1
20070230167 McMahon et al. Oct 2007 A1
20070255110 Wax et al. Nov 2007 A1
20070270866 Von Jako Nov 2007 A1
20070287888 Lovell et al. Dec 2007 A1
20080002426 Vayser et al. Jan 2008 A1
20080027461 Vaquero Jan 2008 A1
20080113312 Ortega May 2008 A1
20080221569 Moore et al. Sep 2008 A1
20080228038 McMahon et al. Sep 2008 A1
20080269564 Gelnett Oct 2008 A1
20080269565 McMahon et al. Oct 2008 A1
20080278936 Kurth et al. Nov 2008 A1
20090018400 Raymond et al. Jan 2009 A1
20090069634 Larkin Mar 2009 A1
20090081611 Hines Mar 2009 A1
20090097236 Miller et al. Apr 2009 A1
20090112068 Grey et al. Apr 2009 A1
20090275803 Krauter et al. Nov 2009 A1
20090287192 Vivenzio et al. Nov 2009 A1
20090312610 Buchok et al. Dec 2009 A1
20100036382 Bonnadier Feb 2010 A1
20100041955 Grey et al. Feb 2010 A1
20100097794 Teng et al. Apr 2010 A1
20100190129 Paz Jul 2010 A1
20100191062 Kieffer Jul 2010 A1
20100292533 Kasahara et al. Nov 2010 A1
20110275894 Mackin Nov 2011 A1
20120055470 Pecherer et al. Mar 2012 A1
20120059226 Funt Mar 2012 A1
20120078060 Swift Mar 2012 A1
20120116170 Vayser et al. May 2012 A1
20120232352 Lin et al. Sep 2012 A1
20120243212 Smith et al. Sep 2012 A1
20130018230 Su et al. Jan 2013 A1
20130021798 Chen et al. Jan 2013 A1
20130041229 Hahn et al. Feb 2013 A2
20130092421 Kajiya Apr 2013 A1
20130102850 Fiorella Apr 2013 A1
20130102887 Thompson et al. Apr 2013 A1
20130109910 Alexander et al. May 2013 A1
20130158345 Majlessi Jun 2013 A1
20130197313 Wan Aug 2013 A1
20130245657 Deville et al. Sep 2013 A1
20130267786 Vayser et al. Oct 2013 A1
20130281784 Ray Oct 2013 A1
20130324801 Grey et al. Dec 2013 A1
20140088371 Vayser et al. Mar 2014 A1
20140179998 Pacey Jun 2014 A1
20140202459 Iqbal Jul 2014 A1
20140228875 Saadat Aug 2014 A1
20140257039 Feldman Sep 2014 A1
20140275790 Vivenzio et al. Sep 2014 A1
20140309499 Swift Oct 2014 A1
20140316211 Hermle Oct 2014 A1
20140323800 Dye Oct 2014 A1
20140323811 DeSantis et al. Oct 2014 A1
20140364695 Nadershahi et al. Dec 2014 A1
20140371536 Miller et al. Dec 2014 A1
20150018625 Miraki et al. Jan 2015 A1
20150157469 Prado et al. Jun 2015 A1
20150238070 Lia et al. Aug 2015 A1
20150285382 Kienreich et al. Oct 2015 A1
20150297217 Huitema et al. Oct 2015 A1
20160000305 Elbaz et al. Jan 2016 A1
20160030128 Duggal et al. Feb 2016 A1
20160038032 Dan Feb 2016 A1
20160066915 Baber et al. Mar 2016 A1
20160081833 Leblanc et al. Mar 2016 A1
20160095506 Dan et al. Apr 2016 A1
20160100751 Davis et al. Apr 2016 A1
20160151058 Ferro et al. Jun 2016 A1
20160302657 Hussey et al. Oct 2016 A1
20170007228 Costabile Jan 2017 A1
20170020621 Huldin et al. Jan 2017 A1
20170059400 Murphy et al. Mar 2017 A1
20170065282 Mathis et al. Mar 2017 A1
20170079518 Elbaz et al. Mar 2017 A1
20170172404 McMahon et al. Jun 2017 A1
20170172555 Shimizu et al. Jun 2017 A1
20170181605 Lalli et al. Jun 2017 A1
20170181607 Lalli et al. Jun 2017 A1
20170181615 Vella et al. Jun 2017 A1
20170181616 Vella et al. Jun 2017 A1
20170224206 Vayser Aug 2017 A1
20170231712 Vayser Aug 2017 A1
20170296162 Wan Oct 2017 A1
20170300623 Rosenblatt et al. Oct 2017 A1
20170303903 De Koning et al. Oct 2017 A1
20170347871 Wallace et al. Dec 2017 A1
20170360423 Stevenson et al. Dec 2017 A1
20180000469 Wood et al. Jan 2018 A1
20180008137 Poormand Jan 2018 A1
20180008138 Thommen et al. Jan 2018 A1
20180008368 Duggal et al. Jan 2018 A1
20180014721 Rullo et al. Jan 2018 A1
20180014842 Shener-Irmakoglu Jan 2018 A1
20180014900 Vayser et al. Jan 2018 A1
20180036095 Vayser et al. Feb 2018 A1
20180042596 Tsubouchi Feb 2018 A1
20180064316 Charles et al. Mar 2018 A1
20180064317 Tesar Mar 2018 A1
20180078301 Vayser Mar 2018 A1
20180116581 Prasad et al. May 2018 A1
20180125336 Goldfarb et al. May 2018 A1
20180125347 Czyzewski et al. May 2018 A1
20180132710 Pacey et al. May 2018 A1
20180132970 Ritter May 2018 A1
20180153391 McMahon et al. Jun 2018 A1
20180156448 Phillips, Jr. et al. Jun 2018 A1
20180206832 Greeley et al. Jul 2018 A1
20180228376 Greenstein et al. Aug 2018 A1
20180228483 Duggal et al. Aug 2018 A1
20180235444 Tsai Aug 2018 A1
20180235592 Kass et al. Aug 2018 A1
20180249902 Grey et al. Sep 2018 A1
20180263480 Lalli et al. Sep 2018 A1
20180271581 Ou et al. Sep 2018 A1
20180280011 Ferro et al. Oct 2018 A1
20180296082 Salvati et al. Oct 2018 A1
20180317746 Lalli et al. Nov 2018 A1
20180317752 Cybulski et al. Nov 2018 A1
20180317902 Green et al. Nov 2018 A1
20180328572 Kennedy et al. Nov 2018 A1
20190038273 Perler et al. Feb 2019 A1
20190049655 Zagatsky et al. Feb 2019 A1
20190076138 Opperman Mar 2019 A1
20190083079 Shimizu et al. Mar 2019 A1
20190133432 Tsai May 2019 A1
20190143006 Vayser et al. May 2019 A1
20190143414 Vayser et al. May 2019 A1
20190150422 Welch May 2019 A1
20190150725 Ramanujam et al. May 2019 A1
20190150739 Wawro et al. May 2019 A1
20190150786 Vassallo et al. May 2019 A1
20190167111 Greenstein et al. Jun 2019 A1
20190167378 Wood et al. Jun 2019 A1
20190190293 Wawro et al. Jun 2019 A1
20190223708 Recanati et al. Jul 2019 A1
20190254512 Spiertz Aug 2019 A1
20190335988 Lia et al. Nov 2019 A1
20190343379 Altamura Nov 2019 A1
20190365217 Hegenberger Dec 2019 A1
20200008694 Karla et al. Jan 2020 A1
20200046216 Moein Feb 2020 A1
20200069171 Miller et al. Mar 2020 A1
20200107714 Bar-Or et al. Apr 2020 A1
20200253467 Lees, Jr. et al. Aug 2020 A1
20200337541 Vivenzio et al. Oct 2020 A1
Foreign Referenced Citations (39)
Number Date Country
2239235 Nov 1996 CN
2265156 Oct 1997 CN
2516109 Oct 2002 CN
2629738 Aug 2004 CN
1565664 Jan 2005 CN
2668152 Jan 2005 CN
1717195 Jan 2006 CN
101179982 May 2008 CN
201055387 May 2008 CN
203591245 May 2008 CN
102415869 Apr 2012 CN
302536685 Aug 2013 CN
103925266 Jul 2014 CN
203898367 Oct 2014 CN
102573700 Dec 2014 CN
2128855 Dec 1972 DE
202004002963 May 2004 DE
202005019780 May 2006 DE
600 33 612 Dec 2007 DE
202010017638 May 2012 DE
0190014 Aug 1986 EP
1074224 Jul 2001 EP
2490478 Mar 1982 FR
2505463 May 2014 GB
2187972 Aug 2002 RU
2308873 Oct 2007 RU
9825512 Jun 1998 WO
0137739 May 2001 WO
0162137 Aug 2001 WO
03082123 Oct 2003 WO
2004064624 Aug 2004 WO
2006107877 Oct 2006 WO
2006107878 Oct 2006 WO
2009137017 Nov 2009 WO
2013-044151 Mar 2013 WO
2014-041172 Mar 2014 WO
2015164881 Oct 2015 WO
2006121530 Nov 2016 WO
2016196788 Dec 2016 WO
Non-Patent Literature Citations (25)
Entry
Solvay, IXEF PARA, pp. 1-8, dated accessed Sep. 25, 2021, webpage https://www.solvay.com/sites/g/files/srpend221/files/2018-10/lxef-PARA-Overview_EN-v2.5_0.pdf (Year: 2016).
European Search Report dated Nov. 23, 2018, that issued in the corresponding European Patent Application No. 16747107.7.
Chinese Office Action, that issued in Chinese Patent Application No. 201711159829.6.
International Search Report of PCT/US2018/054925, dated Oct. 9, 2018.
Pankaj Saxena, et al., Hydrodissection Technique of Harvesting Left Internal Thoracic Artery, Department of Cardiac Surgery, The Prince Charles Hospital, Chermside, Brisbane, Queensland, Australia, Thoracic Artery, Ann Thorac Surg., 2005; 80:335-6.
Supplementary European Search Report dated Apr. 24, 2019, that issued in European Patent Application No. 16804432.9.
OBP Medical—OfficeSPEC, Premier Speculum for In-Office Procedures published Nov. 30, 2009 (1 page).
OBP Medical—ER-SPEC OBGYN Brochure published Nov. 19, 2014 (2 pages).
OBP Medical—ER-SPEC Brochure, Light Source Now 10X Brighter published Oct. 30, 2012 (1 page).
OBP Medical—ER-SPEC Product Presentation published Apr. 16, 2014 (12 pages).
OBP Medical—ER-SPEC Brochure published Apr. 11, 2013 (2 pages).
OBP Medical—ER-SPEC Brochure published Feb. 4, 2013 (2 pages).
OBP Medical—ER-SPEC Brochure, Light Source Now 10X Brighter published Jan. 23, 2013 (1 page).
International Search Report for International application No. PCT/US2016/016154 dated May 19, 2016 for corresponding U.S. application, U.S. Appl. No. 14/614,413.
International Search Report, for International application No. PCT/US2016/035508 dated Sep. 15, 2016 for corresponding U.S. application, U.S. Appl. No. 15/171,581.
International Search Report for International application No. PCT/US2016/036833 dated Jan. 19, 2017.
Office Action issued in U.S. Appl. No. 15/171,581.
PCT Search Report issued in PCT Application No. PCT/US2017/042617.
Nov. 1, 2017 Chinese Office Action, that issued in Chinese Patent Application No. 201510543086.7.
Jul. 16, 2018 Chinese Office Action, that issued in Chinese Patent Application No. 201510543086.7.
Solvey, Techinical Data Sheet, Ixef 1022 polyarylamide, Feb. 13, 2015, pp. 1-5.
http://www.makeitfrom.com/material-properties/Polyetheretheketone-PEEK, printed on Oct. 9, 2016, pp. 1-9.
Redefining illumination, Eikon LT Adapt SE For optimal precision and protection (2019), Stryker, www.stryker.com/surgical (3 pages).
Supplementary European Search Report dated Oct. 29, 2019, that issued in European Patent Application No. 1690811.3.
Supplementary European Search Report dated Oct. 6, 2021 issued in European Application No. 19757432.0.
Related Publications (1)
Number Date Country
20190350571 A1 Nov 2019 US
Continuations (1)
Number Date Country
Parent 15178675 Jun 2016 US
Child 16511922 US
Continuation in Parts (1)
Number Date Country
Parent 14614413 Feb 2015 US
Child 15178675 US